ArticlePloS one2026
Hospital-based descriptive epidemiology of intracranial meningiomas in Palestine: A retrospective study from a major referral center (2018-2023).
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIntracranial meningioma is the most common type of primary brain tumor globally. This study aimed to determine the epidemiological characteristics of intracranial meningioma in Palestine from 2018 to 2023.
methodsWe conducted a retrospective hospital-based descriptive study of radiologically and histologically confirmed intracranial meningiomas treated or referred to Al-Makassed Hospital, the main neurosurgical referral center in Palestine, from September 7th, 2023, to November 16th, 2023. Patients' reports were the main source for data collection. Histopathological types of meningioma were coded according to the 2016 WHO Classification for CNS tumors. The incidence rates of intracranial meningiomas were hospital-based referral-center minimum estimates, calculated based on the total population size.
resultsA total of 204 cases of intracranial meningioma were identified. The mean age at diagnosis was 51.12 years (±13.96). The estimated minimum hospital-based crude incidence rate was 0.65 per 100,000 person-years (95% CI: 0.56-0.75), with a higher incidence in females than in males (0.88 vs 0.43, (0.88 vs 0.43 per 100,000 person-years, IRR = 2.07 [95% CI: 1.53-2.81]; p = 0.003). Grade I meningiomas were the most common, accounting for 81.4%. Grade II and III meningiomas were more common in males. Focal Neurological Symptoms (39.7%) were the most prevalent presenting symptoms. Intracranial meningiomas were most often managed with surgical resection alone (96.6%).
conclusionThis study provided insights into the epidemiological characteristics of meningioma in Palestine. These findings represent hospital-based minimum estimates and are not directly comparable to population-based registry data. Meningiomas were more common in females, while higher-grade meningiomas were more common in males. Further research is needed to ascertain the most common subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.